Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 6, 2013
Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right
Thomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology
|
September 6, 2002
HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?
Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology
|
January 5, 2002
Angiotensin II (AT(1)) receptor antagonists, diabetes, and nephropathy: do differences between the renal and systemic circulations explain the outcomes observed with ARBs and ACE inhibitors?
Thomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology
|
January 1, 1993
Aspects of the Use of Angiotensin-Converting Enzyme Inhibitors and Calcium Antagonists in Treatment of Heart Failure in the Older Patient
Thomas D Giles, Gary E. Sander
The American Journal of Geriatric Cardiology
|
July 31, 2003
ALLHAT and ANBP2: what have we learned from recent mega-trials?
Gary E Sander, Thomas D Giles
Current Hypertension Reports
|
November 7, 2002
Hypertension and lipids: lipid factors in the hypertension syndrome
Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology
|
December 28, 2002
Statin therapy in the elderly-the evidence mounts
Gary E Sander, Thomas D Giles
The American Heart Hospital Journal
|
April 9, 2005
Diabetes mellitus and heart failure
Gary E Sander, Thomas D Giles
Current Cardiology Reports
|
October 6, 2011
What is the blood pressure goal for the elder patient 75 years of age or older?
Gary E Sander, Thomas D Giles
Journal of Investigative Medicine High Impact Case Reports
|
February 24, 2016
Stress Cardiomyopathy in the Setting of COPD Exacerbation
Kevin Landefeld, Qusai Saleh, Gary E Sander
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 6, 2013
Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right
Thomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology
|
September 6, 2002
HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?
Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology
|
January 5, 2002
Angiotensin II (AT(1)) receptor antagonists, diabetes, and nephropathy: do differences between the renal and systemic circulations explain the outcomes observed with ARBs and ACE inhibitors?
Thomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology
|
January 1, 1993
Aspects of the Use of Angiotensin-Converting Enzyme Inhibitors and Calcium Antagonists in Treatment of Heart Failure in the Older Patient
Thomas D Giles, Gary E. Sander
The American Journal of Geriatric Cardiology
|
July 31, 2003
ALLHAT and ANBP2: what have we learned from recent mega-trials?
Gary E Sander, Thomas D Giles
Current Hypertension Reports
|
November 7, 2002
Hypertension and lipids: lipid factors in the hypertension syndrome
Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology
|
December 28, 2002
Statin therapy in the elderly-the evidence mounts
Gary E Sander, Thomas D Giles
The American Heart Hospital Journal
|
April 9, 2005
Diabetes mellitus and heart failure
Gary E Sander, Thomas D Giles
Current Cardiology Reports
|
October 6, 2011
What is the blood pressure goal for the elder patient 75 years of age or older?
Gary E Sander, Thomas D Giles
Journal of Investigative Medicine High Impact Case Reports
|
February 24, 2016
Stress Cardiomyopathy in the Setting of COPD Exacerbation
Kevin Landefeld, Qusai Saleh, Gary E Sander
Page
of 4